Clin2
NCT06968624Possibly a fitNot yet recruiting

Ketamine for shingles pain with depression

Depression DisordersHerpetic Neuralgia

Part of Infections, Mental health, Pain clinical trials.

This trial tests if ketamine can help people who have long-term shingles pain and also feel depressed. It aims to see if the treatment can reduce both pain and depression.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
50 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have had shingles-related pain for more than 1 month
  • You have symptoms of depression (confirmed by a doctor's evaluation or a score of 8 or higher on a depression questionnaire)
  • You are between 18 and 65 years old
  • Your body mass index (BMI) is under 30
  • You are not allergic to ketamine
  • You do not have other mental health conditions like anxiety, severe high blood pressure, or serious heart, lung, liver, or kidney problems

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06896994Recruiting
Study of esketamine plus pregabalin and duloxetine for shingles nerve pain

This trial tests whether adding esketamine to two standard pain medicines (pregabalin and duloxetine) can better treat nerve pain from shingles that persists for months. It's for people whose pain hasn't improved enough with pregabalin alone.

Beijing, Beijing Municipality
NCT06914206Not yet recruiting
Esketamine plus nerve treatment for shingles pain

This study tests a combination of a nasal spray medicine (esketamine) and a nerve treatment (pulsed radiofrequency) to reduce severe shingles pain. It may help people who have had shingles pain for less than 3 months and are already scheduled for the nerve procedure.

Beijing, Beijing Municipality
NCT06668571Recruiting· Phase 2
Ketamine for treatment-resistant depression

This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.

Rochester, Minnesota
NCT07247006Not yet recruiting· Phase 2
Ketamine with therapy for hard-to-treat depression

This trial is testing whether a combination of ketamine and talk therapy can help people with depression that hasn't responded to other treatments. You will receive ketamine in a safe, supervised setting while working with a therapist.

Rochester, New York
NCT06914180Not yet recruiting
Esketamine with pulse radiofrequency for shingles nerve pain in face

This trial tests whether adding esketamine (a fast-acting pain medicine) to a standard nerve treatment called pulse radiofrequency (PRF) can better relieve lasting facial pain from shingles. It may help people who still have pain in the face or head after shingles.

Beijing, Beijing Municipality
NCT05327699Recruiting· Early Phase 1
Ketamine study for depression with reduced pleasure

This early-phase study tests whether ketamine can help people with major depression who have trouble feeling pleasure. It also studies how the brain may change in response to stress, to better understand who might respond to treatment.

Atlanta, Georgia

Hear when a new Depression Disorders trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.